García-Lluch, G.; Peña-Bautista, C.; Royo, L.M.; Baquero, M.; Cañada-Martínez, A.J.; Cháfer-Pericás, C.
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study. Pharmaceutics 2023, 15, 924.
https://doi.org/10.3390/pharmaceutics15030924
AMA Style
García-Lluch G, Peña-Bautista C, Royo LM, Baquero M, Cañada-Martínez AJ, Cháfer-Pericás C.
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study. Pharmaceutics. 2023; 15(3):924.
https://doi.org/10.3390/pharmaceutics15030924
Chicago/Turabian Style
García-Lluch, Gemma, Carmen Peña-Bautista, Lucrecia Moreno Royo, Miguel Baquero, Antonio José Cañada-Martínez, and Consuelo Cháfer-Pericás.
2023. "Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study" Pharmaceutics 15, no. 3: 924.
https://doi.org/10.3390/pharmaceutics15030924
APA Style
García-Lluch, G., Peña-Bautista, C., Royo, L. M., Baquero, M., Cañada-Martínez, A. J., & Cháfer-Pericás, C.
(2023). Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study. Pharmaceutics, 15(3), 924.
https://doi.org/10.3390/pharmaceutics15030924